Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03744 |
| Species: | Homo sapiens |
| Position : | chr8:128482317-128483854 |
| Year: | 2009 |
| Title: | The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. |
| Genome Build: | hg18 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | colorectal cancer |
| PMID: | 19561607 |
| MONDO: | MONDO:0005575 |
| Tissue: | ascitic fluid |
| Tissue Ontology ID: | UBERON:0007795 |
| Cell Source: | COLO 205 |
| CVCL ID: | CVCL_0218 |
| Cell Type: | epithelial cell of colon |
| Experiment Type: | Enhancer activity assay; Chromatin interaction assay; Allele-specific regulatory assay; Enhancer chromatin-state assay |
| High Throughput Method: | NimbleGen 8q24 high-density tiling array |
| Low Throughput Method: | Luciferase reporter assay; allele-specific reporter assay; p300 ChIP-qPCR; H3K4me1 ChIP-qPCR; H3K4me3 ChIP-qPCR; RNA polymerase II ChIP-qPCR; 3C; competitive PCR |
| Target gene : | MYC |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|